Biology Reference
In-Depth Information
[83] Koyama M, Kuns RD, Olver SD, Raffelt NC, Wilson YA, Don AL, et al. Recipient
nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute
graft-versus-host disease. Nat Med 2012;18(1):135-42.
[84] Valujskikh A, Lantz O, Celli S, Matzinger P, Heeger PS. Cross-primed CD8(+) T cells
mediate graft rejection via a distinct effector pathway. Nat Immunol 2002;3(9):844-51.
[85] Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, Lira SA, et al. Depletion of
host Langerhans cells before transplantation of donor alloreactive T cells prevents skin
graft-versus-host disease. Nat Med 2004;10(5):510-7.
[86] Segura E, Guerin C, Hogg N, Amigorena S, Thery C. CD8+ dendritic cells use
LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol
2007;179(3):1489-96.
[87] Qu C, Nguyen VA, Merad M, Randolph GJ. MHC class I/peptide transfer between
dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that
engulf dying cells. J Immunol 2009;182(6):3650-9.
[88] Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune
responses. Nat Rev Immunol 2009;9(8):581-93.
[89] Wakim LM, Bevan MJ. Cross-dressed dendritic cells drive memory CD8+ T-cell activa-
tion after viral infection. Nature 2011;471(7340):629-32.
[90] Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR, et al. Acute graft-versus-
host disease does not require alloantigen expression on host epithelium. [comment]
[erratum appears in Nat Med 2002 Sep;8(9):1039]. Nat Med 2002;8(6):575-81.
[91] Duffner UA, Maeda Y, Cooke KR, Reddy P, Ordemann R, Liu C, et al. Host dendritic
cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol
2004;172(12):7393-8.
[92] Li H, Matte-Martone C, Tan HS, Venkatesan S, McNiff J, Demetris AJ, et al. Graft-versus-
host disease is independent of innate signaling pathways triggered by pathogens in
host hematopoietic cells. J Immunol 2011;186(1):230-41.
[93] Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol
2002;2(3):151-61.
[94] Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007;7(5):340-52.
[95] Heath WR, Carbone FR. Dendritic cell subsets in primary and secondary T cell re-
sponses at body surfaces. Nat Immunol 2009;10(12):1237-44.
[96] Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, Caminschi I, et al. Cross-
presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat
Immunol 2009;10(5):488-95.
[97] Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, et al. Origin of the
lamina propria dendritic cell network. Immunity 2009;31(3):513-25.
[98] Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA, et al. Cross-
presentation, dendritic cell subsets, and the generation of immunity to cellular anti-
gens. Immunol Rev 2004;199:9-26.
[99] Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells
and other langerin-expressing dendritic cells. Nat Rev Immunol 2008;8(12):935-47.
[100] Pooley JL, Heath WR, Shortman K. Cutting edge: intravenous soluble antigen is pre-
sented to CD4 T cells by CD8− dendritic cells, but cross-presented to CD8 T cells by
CD8+ dendritic cells. J Immunol 2001;166(9):5327-30.
[101] Kim TD, Terwey TH, Zakrzewski JL, Suh D, Kochman AA, Chen ME, et al. Organ-
derived dendritic cells have differential effects on alloreactive T cells. Blood
2008;111(5):2929-40.
[102] Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, et al.
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature
2003;424(6944):88-93.
[103] Mora JR, Cheng G, Picarella D, Briskin M, Buchanan N, von Andrian UH. Reciprocal
and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-
associated lymphoid tissues. J Exp Med 2005;201(2):303-16.
[104] Zhang Y, Louboutin JP, Zhu J, Rivera AJ, Emerson SG. Preterminal host dendritic cells
in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin
Invest 2002;109(10):1335-44.
[105] Koyama M, Kuns RD, Olver SD, Raffelt NC, Wilson YA, Don AL, et al. Recipient nonhe-
matopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-
host disease. Nat Med 2011;18(1):135-42.
[106] Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, et al. In vivo deple-
tion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-
associated antigens. Immunity 2002;17(2):211-20.
[107] Leonhardt F, Zirlik K, Buchner M, Prinz G, Hechinger AK, Gerlach UV, et al. Spleen
tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels.
Leukemia 2012;26(7):1617-29.
192
Search WWH ::
Custom Search